Chemical Compound

Oxaliplatin Imp. A (EP); Oxaliplatin USP Related Compound A; Oxaliplatin USP RC A; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-Naphthacenecarboxamide Dihydrate; (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; 5-Hydroxytetracycline Dihydrate; Oxytetracycline Dihydrate

Brand: EASY CDMO
SKU: 54680691

CAS Registry Number 6153-64-6

返回搜索申请报价

Primary record

Oxaliplatin Imp. A (EP); Oxaliplatin USP Related Compound A; Oxaliplatin USP RC A; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-Naphthacenecarboxamide Dihydrate; (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; 5-Hydroxytetracycline Dihydrate; Oxytetracycline Dihydrate

库存: 1,859 克
纯度: 99.4 %
CAS: 6153-64-6

化合物标识与属性

CAS: 6153-64-6
PubChem CID: 54680691
SMILES: C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.O.O
Canonical SMILES: CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.O.O

名称与同义词

Oxytetracycline dihydrate
oxytetracycline
Terramycin
Oxitetracycline
Oxytetracyclin
Terrafungine
Terramycine
Nitox
OXTC
6153-64-6
Oxytetracyclini dihydras
Terramycin (TN)
Hydroxytetrazyklindihydrat
Prestwick_630
Oxytetracyclinium dihydricum
Oxytetracyclinedihydrate
AC1NQZYS
Neo-oxy 50/50
Oxytetracycline (dihydrate)
CCRIS 9079
UNII-X20I9EN955
SCHEMBL2898
5-Hydroxytetracycline Dihydrate
OXYTETRACYCLINE [JAN]
MFCD00151234
OXYTETRACYCLINE [VANDF]
C22H24N2O9.2H2O
DTXCID203412
orb1300607
X20I9EN955
CHEMBL1892210
DTXSID4023412
OXYTETRACYCLINE [USP-RS]
SCHEMBL23359135
HY-B0275B
Oxytetracycline (JAN/USP/INN)
Oxytetracycline [BAN:INN:JAN]
MSK4131
IMLJLCJZQLGHJS-JEKSYDDFSA-N
Oxytetracycline [USP:INN:BAN:JAN]
SRRPEXWCHWWJOC-JEKSYDDFSA-N
C22H24N2O9
HMS1568N16
HMS2095N16
HMS3712N16
Oxytetracycline [USAN:INN:BAN:JAN]
C22H28N2O11
OXYTETRACYCLINE [GREEN BOOK]
Tox21_111711
Tox21_300679
OXYTETRACYCLINE [ORANGE BOOK]
s2052
AKOS025310865
CCG-220307
CID5282371
FO26719
NSC 757262
NSC-757262
OXYTETRACYCLINE [USP MONOGRAPH]
NCGC00091268-03
NCGC00159490-02
NCGC00254587-01
Oxytetracycline, disodium salt, dihydrate
AS-75285
C22-H24-N2-O9.2H2-O
OXYTETRACYCLINE DEHYDRATE [WHO-IP]
OXYTETRACYCLINE DIHYDRATE [WHO-DD]
Q412
SY067495
CAS-6153-64-6
LS-176184
B2001
CS-0013155
OXYTETRACYCLINE DIHYDRATE [GREEN BOOK]
C75886
D00205
OXYTETRACYCLINE DIHYDRATE [EP MONOGRAPH]
OXYTETRACYCLINUM DIHYDRAS [WHO-IP LATIN]
112702-EP2280007A1
112702-EP2295437A1
112702-EP2298775A1
SR-01000003006
SR-01000003006-6
(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide dihydrate
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide dihydrate
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, dihydrate, (4S,4aR,5S,5aR,6S,12aS)-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, dihydrate
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, dihydrate, (4S,4aR,5S,5aR,6S,12aS)-
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione dihydrate
(4S,4aR,5S,5aR,6S,12aS,Z)-2-(amino(hydroxy)methylene)-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione dihydrate
[4S-(4a,4a-a,5a,5a-a,6b,12a-a]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a -octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-n aphthacenecarboxamide Dihydrate
[4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate
2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,5,6,10,12,12A-HEXAHYDROXY-6-METHYL-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5.ALPHA.,5A.ALPHA.,6.BETA.,12A.ALPHA.))-, DIHYDRATE
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, dihydrate, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,dihydrate
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,dihydrate, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-
OTC
Oxaliplatin Imp. A (EP); Oxaliplatin USP Related Compound A; Oxaliplatin USP RC A; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-Naphthacenecarboxamide Dihydrate; (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; 5-Hydroxytetracycline Dihydrate; Oxytetracycline Dihydrate